[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@biospace Avatar @biospace BioSpace

BioSpace posts on X about sanofi, vivo, regeneron, $4523t the most. They currently have XXXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXXXXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence

Social category influence stocks XXXX% finance XXXX% technology brands XXXX%

Social topic influence sanofi 3.13%, vivo 3.13%, regeneron 3.13%, $4523t 3.13%, johnson johnson 3.13%, weight loss 3.13%, closed 3.13%, ai 3.13%, novartis 3.13%, weightloss XXXX%

Top accounts mentioned or mentioned by @biopharmiq @tgtherapeutics @truedat999 @beamtx @stock6996 @yaireinhorn

Top assets mentioned Sanofi (SNY) Johnson & Johnson (JNJ) Novartis AG (NVS)

Top Social Posts

Top posts by engagements in the last XX hours

"The FDA has informed Merck Sanofi and AstraZeneca of the safety investigation into their RSV antibodies though it remains unclear what regulatory action if any will be taken. #FDA #vaccines #RSV #biospace"
X Link 2025-12-10T16:29Z 25.5K followers, XXX engagements

"The centerpiece of the deal is the in vivo editor TSRA-196 which in preclinical studies has shown robust editing at SERPINA1 the locus linked to alpha-1 antitrypsin deficiency. #geneediting #pharma #biospace"
X Link 2025-12-01T18:06Z 25.5K followers, XXX engagements

"Protego Biopharma is advancing a small-molecule drug that helps light chain proteins fold correctly in turn addressing the underlying biological cause of AL amyloidosis. #biopharma #seriesb #biospace"
X Link 2025-12-01T19:05Z 25.4K followers, XXX engagements

"Following FDA rejections Regeneron and Scholar Rock are turning to other facilities to clear regulatory logjams created by quality problems at an ex-Catalent facility in Indiana. Novo Nordisk meanwhile has been tight-lipped about whether its own FDA applications have been affected. #FDA #regulatory #manufacturing #biospace"
X Link 2025-12-02T14:47Z 25.5K followers, XXX engagements

"While the TrumpRx deals only cover Lilly and Novo for now the agreements are good for any cardiometabolic biotechs waiting in the wings according to a new 2026 preview report from PitchBook. #venturecapital #GLP1 #biotech #biospace"
X Link 2025-12-03T15:08Z 25.4K followers, XXX engagements

"Analysts had noted unease from investors regarding the state of the Phase III ADEPT-2 trial with BMS at one point telling Leerink Partners that the reopening of enrollment would be a significant development. #alzheimers #biospace"
X Link 2025-12-03T17:06Z 25.5K followers, XXX engagements

"Days after Johnson & Johnsons posdinemab failed to slow clinical decline in patients with Alzheimers disease Eisai Chief Clinical Officer Lynn Kramer expressed unwavering conviction in his companys own anti-tau asset while others suggest the Alzheimers field is heading in a completely different direction. #alzheimers #pharma #biospace"
X Link 2025-12-05T13:56Z 25.5K followers, XXX engagements

"The R&D pipeline for depression therapies faced a demoralizing 2025 as five high-profile candidates including KOR antagonists by Johnson & Johnson and Neumora Therapeutics flunked late-stage clinical trials underscoring the persistent challenges of CNS drug development"
X Link 2025-12-08T21:03Z 25.5K followers, XXX engagements

"Structures aleniglipron elicited over XX% weight loss in a Phase II trial sending the biotechs stock up nearly XXX% as markets closed on Monday. #obesity #GLP1 #weightloss #biospace"
X Link 2025-12-09T16:03Z 25.5K followers, XXX engagements

"At the heart of the deal is Relations Lab-in-the-Loop platform which uses AI models to improve understanding of diseases and guide clinical development programs. #AI #biospace"
X Link 2025-12-09T16:29Z 25.5K followers, XXX engagements

"TERN-701 more than doubled the response rate of Novartis rival approved therapy in an early-stage trial sending the biotechs shares flying. #clincaltrials #biotech #biospace"
X Link 2025-12-09T18:05Z 25.5K followers, XXX engagements

"After a series of unfortunate regulatory rejections and manufacturing issues surfaced Regenerons shares dipped to $XXX this summerthe lowest theyd been since early 2021. But they now sit higher than they did at the start of the year. #regulatory #manufacturing #biospace"
X Link 2025-12-10T14:10Z 25.5K followers, XXX engagements

"The partnership will focus on Crescents PD-1/VEGF inhibitor CR-001 and Kelun-Biotechs SKB105 both of which the companies plan to push into Phase I/II development for solid tumors early next year. #biotech #biospace"
X Link 2025-12-04T17:25Z 25.5K followers, XXX engagements

"Although still in Phase I Wave Life Sciences injectable RNA weight loss treatment achieved results that impressed analysts with X% fat reduction after three months beating Novo Nordisks semaglutide at a similar time point. #weightloss #obesity #biospace"
X Link 2025-12-09T14:02Z 25.5K followers, XXX engagements

"Contract manufacturer Adare Pharma Solutions will part ways with XXX employees as it closes down a production facility in Philadelphia. The layoffs will take effect from March X through June XX next year. #layoffs #pharma #biospace"
X Link 2025-12-11T19:09Z 25.5K followers, XXX engagements